Chemical Properties of 4'-Hydroxystanozolol (5A-Androstan-17A-methyl-4',17B-diol-3,2c-pyrazol), TMS

4'-Hydroxystanozolol (5A-Androstan-17A-methyl-4',17B-diol-3,2c-pyrazol), TMS

PDF Excel Molecule Calculator
InChI
InChI=1S/C27H48N2O2Si2/c1-25-16-18-17-28-29-23(18)24(30-32(4,5)6)22(25)11-10-19-20(25)12-14-26(2)21(19)13-15-27(26,3)31-33(7,8)9/h17,19-22,24H,10-16H2,1-9H3,(H,28,29)/t19-,20?,21?,22+,24-,25-,26+,27+/m0/s1
InChI Key
AZJYUUNJZKMMLR-HMHGHBMXSA-N
Formula
C27H48N2O2Si2
SMILES
CC12Cc3c[nH]nc3C(O[Si](C)(C)C)C1CCC1C2CCC2(C)C1CCC2(C)O[Si](C)(C)C
Molecular Weight1
488.85
Cheméo is a service of Céondo GmbH, since 2007, we provide simulation, modelling and software development services for the industry. Do not hesitate to contact us for your projects.

Physical Properties

Property Value Unit Source
log10WS -3.41 Crippen Calculated Property
logPoct/wat 6.845 Crippen Calculated Property
Inp 3233.00 NIST

Similar Compounds

5«alpha»-Androstan-17«alpha»-methyl-4«beta»,17«beta»-diol-3,2c-pyrazol, TMS. Leu-Trp, N-trimethylsilyl-, trimethylsilyl ester. Ethylmorphine, trimethylsilyl ether. Buprenorphine. Dihydroergokryptine. Crinan-11-ol, 1,2-didehydro-3-methoxy-, (3«beta»,5«alpha»,11R,13«beta»,19«alpha»)-. [2,2'-Bimorphinan]-3,3',6,6'-tetrol, 7,7',8,8'-tetradehydro-4,5:4',5'-diepoxy-17,17'-dimethyl-, (5«alpha»,6«alpha»)-(5'«alpha»,6'«alpha»)-. Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5«alpha»,6«alpha»)-, bis(trifluoroacetate) (ester). Triazolo[4,5-d]pyrimidin-7-ol,3h-v-, 5-amino-3-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-, 5'-diphenyl phosphate (keto form). Deserpidine. Paclitaxel. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'«alpha»,10«alpha»)-. Ergotamine. Ergocristine. Codeine-propionyl.

Find more compounds similar to 4'-Hydroxystanozolol (5A-Androstan-17A-methyl-4',17B-diol-3,2c-pyrazol), TMS.

Sources

Note: Cheméo is only indexing the data, follow the source links to retrieve the latest data. The source is also providing more information like the publication year, authors and more. Take the time to validate and double check the source of the data.